Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of renoprotective efficacy between azilsartan medoxomil and enalapril
TCTR20220426002Phase 4Completed
- Sponsor
- Phramongkutklao Hospital Foundation
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic kidney disease (CKD) and hypertension (HTN) comparing Azilsartan medoxomil arm with Enalapril arm (2 arms). Started Apr 2018; status: completed.
02
Drugs
azilsartan medoxomilenalapril
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)
Beyond the preview
Go deeper on TCTR20220426002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220426002.